Inhibition of Corneal Neovascularization by Topical and Subconjunctival Tigecycline

<table>The percentage of corneal neovascularization by groups. Subconjunctivally tigecycline-treated eyes (group 3) showed significantly less corneal neovascularization than other groups.</table>

Journal of Ophthalmology

fig2

Figure 2

Figure 2: Inhibition of Corneal Neovascularization by Topical and Subconjunctival Tigecycline 